Factors related to in-hospital deaths in patients with tuberculosis

Archives of Internal Medicine

Volumn 158, Issue 17, 1998, Pages 1916-1922

  Sacks, Leonard Vernon ^a   Pendle, Stella ^a  

^a Rietfontein Trop Diseases Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ETHAMBUTOL; HEMOGLOBIN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CAVITATION; LUNG FIBROSIS; LUNG INFILTRATE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTH AFRICA; THORAX RADIOGRAPHY; TUBERCULOSIS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TUBERCULOSIS;

EID: 0032575851     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.17.1916     Document Type: Article

References (25)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72:213-220.
2. Jones BE, Maung MO, Taikwel EK, et al. CD4 cell counts in human immuno-deficiency virus-negative patients with tuberculosis. Clin Infect Dis. 1997;24: 988-991.
3. Wallis RS, Helfand MS, Whalen CC, et al. Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis. Tuber Lung Dis. 1996;77: 516-523.
4. Gordin FM, Matts JP, Miller C, et al. A controlled trial of isoniazid in persons with anergy human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med. 1997;37:315-320.
5. Perenboom RM, Richter C, Swai ABM, et al. Clinical features of HIV seropositive and HIV seronegative patients with tuberculous lymphadenitis in Dar es Salaam. Tuber Lung Dis. 1995;76:401-406.
6. Small PM, Schechter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991;324:289-294.
7. Selvaraj P, Reetha AM, Uma H, Xavier B, Prabhakar R, Narayanan PR. Influence of HLA-DR and -DQ phenotypes on tuberculin reactive status in pulmonary tuberculosis patients. Tuber Lung Dis. 1996;77:369-373.
8. Chaisson RE, Scheeter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immure deficiency syndrome. Am Rev Respir Dis. 1987;136:570-574.
9. Klein NC, Duncanson FP, Lenox TH, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest. 1989;95:1190-1192.
10. Epi Info [computer program]. Version 6. Atlanta, Ga: Centers for Disease Control and Prevention; 1994.
11. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. JAMA. 1995;273:220-226.
12. Pablos Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all cause mortality in patients with tuberculosis. JAMA. 1996;276:1223-1228.
13. Stoneburner R, Laroche E, Prevots R, et al. Suvival in a cohort of human immunodeficiency virus infected tuberculosis patients in New York City: implications for the expansion of the AIDS case definition. Arch Intern Med. 1992;152: 2033-2037.
14. Nunn P, Brindle R, Carpenter L, et al. Cohort study of HIV infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (6 month) mortality. Am Rev Respir Dis. 1992;146:849-854.
15. Small PM, Schechter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991;324:289-294.
16. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis. 1997;24: 661-668.
17. Braun MM, Cote TR, Rabkin CS. Trends in death with tuberculosis during the AIDS era. JAMA. 1993;269:2865-2868.
18. Fischl MA, Daikos GL, Uttamchandani RB, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis causes by multidrug resistant bacilli. Ann Intern Med. 1992;117:184-190.
19. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Intern Med. 1992;117:191-196.
20. Post FA, Wood R. HIV infection is not associated with an increased rate of drug-resistant tuberculosis. S Afr Med J. 1997;87:903.
21. Di Perri G, Cazzadori A, Vento S, et al. Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients. Tuber Lung Dis. 1996;77:244-249.
22. Gallant JE, Ko AH. Cavitary pulmonary lesions in patients infected with human immunodeficiency virus. Clin Infect Dis. 1996;22:671-682.
23. Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J. Why do our patients die of active tuberculosis in the era of effective therapy? Tuber Lung Dis. 1994:75; 329-333.
24. World Health Assembly. Report of the 44th World Health Assembly, Tuberculosis Control Programme. Geneva, Switzerland: World Health Assembly; 1991. Resolution WHA 44.8
25. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a west African city. AIDS. 1993;7:1569-1579.